Contact
searchSearch
HMP Global
Login

Advertisement

Advertisement

ADVERTISEMENT

March 2020

Column

Real-World Data Analysis and Considerations for Use
Editor's Page
Real-World Data Analysis and Considerations for Use
03/16/2020
Winston Wong, PharmD, Editor-in-Chief
Google the question “what is real-world evidence.” One of the first citations will be a link to the Food and Drug Administration (FDA) page defining both real-world evidence (RWE) and real-world data (RWD). The FDA...
Google the question “what is real-world evidence.” One of the first citations will be a link to the Food and Drug Administration (FDA) page defining both real-world evidence (RWE) and real-world data (RWD). The FDA...
Google...
03/16/2020
Journal of Clinical Pathways
Financial Advocacy Network: Hub for Education, Resources, and Peer-to-Peer Learning
Trending From ACCC
Financial Advocacy Network: Hub for Education, Resources, and Peer-to-Peer Learning
03/16/2020
JCP Editors
Over the past decade, the field of oncology has seen remarkable advances stemming from a better understanding of the molecular biology of many cancer types. This growing body of knowledge has led to improvements in...
Over the past decade, the field of oncology has seen remarkable advances stemming from a better understanding of the molecular biology of many cancer types. This growing body of knowledge has led to improvements in...
Over...
03/16/2020
Journal of Clinical Pathways
Where Incentives Align (or Don’t) Among Health Care Stakeholders and How They Are Evolving
Pharma Insights
Where Incentives Align (or Don’t) Among Health Care Stakeholders and How They Are Evolving
03/16/2020
Avi Mamidi, PharmD
Elizabeth Oyekan, PharmD, FCSHP, CPHQ
Jeremy Schafer, PharmD, MBA
Larry Blandford, PharmD—Column Editor
The goal of all health care stakeholders—payers, providers, and health systems—is to lower health care costs and improve patient health outcomes, yet the path to getting to this goal remains questionable, partially...
The goal of all health care stakeholders—payers, providers, and health systems—is to lower health care costs and improve patient health outcomes, yet the path to getting to this goal remains questionable, partially...
The...
03/16/2020
Journal of Clinical Pathways
Building Episodes of Care Models for Oncology & Other Chronic Conditions
Engaging Payers
Building Episodes of Care Models for Oncology & Other Chronic Conditions
03/16/2020
Lili Brillstein, MPH—Column Editor
The episodes of care payment model is designed to put the patient at the center of care delivery, with their care coordinated among all providers for more comprehensive care to achieve the best possible outcomes....
The episodes of care payment model is designed to put the patient at the center of care delivery, with their care coordinated among all providers for more comprehensive care to achieve the best possible outcomes....
The...
03/16/2020
Journal of Clinical Pathways
Proactive Steps to Ensure Appropriate Utilization of the First Disease-Modifying Therapy for Alzheimer Disease
Clinical Pathways GPS
Proactive Steps to Ensure Appropriate Utilization of the First Disease-Modifying Therapy for Alzheimer Disease
03/16/2020
Richard G Stefanacci, DO, MGH, MBA, AGSF, CMD—Column Editor
Matthew Pakizegee, PharmD, MS
Jonathan W Hodgson, MBA
Chad McAuliffe
Widespread hope exists that aducanumab will soon gain Food and Drug Administration approval as the first disease-modifying therapy for patients with mild cognitive impairment associated with Alzheimer disease (AD),...
Widespread hope exists that aducanumab will soon gain Food and Drug Administration approval as the first disease-modifying therapy for patients with mild cognitive impairment associated with Alzheimer disease (AD),...
...
03/16/2020
Journal of Clinical Pathways

Insights

Real-World Analysis Potential Impact on Standard Management of Tumor Lysis Syndrome in Adults With Leukemia, Lymphoma
Interview
Real-World Analysis Potential Impact on Standard Management of Tumor Lysis Syndrome in Adults With Leukemia, Lymphoma
03/16/2020
JCP Editors
An interview with Scott C Howard, MD, MSc, University of Tennessee Health Sciences Center, Memphis TN. Many health professionals are talking about the use of real-world data and evidence to advance medical...
An interview with Scott C Howard, MD, MSc, University of Tennessee Health Sciences Center, Memphis TN. Many health professionals are talking about the use of real-world data and evidence to advance medical...
An...
03/16/2020
Journal of Clinical Pathways
Making the Switch to Biosimilars With Clinical Pathways
Column
Making the Switch to Biosimilars With Clinical Pathways
03/16/2020
Gary H Lyman, MD, MPH, FASCO, FRCP, FACP
This section called “CME Corner,” highlights, when available, relevant continuing medical education (CME) opportunities deemed to be of use to readers. Articles include an overview of a specific area where key...
This section called “CME Corner,” highlights, when available, relevant continuing medical education (CME) opportunities deemed to be of use to readers. Articles include an overview of a specific area where key...
This...
03/16/2020
Journal of Clinical Pathways
Navigating the Complexities of Novel Treatment Sequencing for AML
Column
Navigating the Complexities of Novel Treatment Sequencing for AML
03/16/2020
Daniel A Pollyea, MD, MS
This section called “CME Corner,” highlights, when available, relevant continuing medical education (CME) opportunities deemed to be of use to readers. Articles include an overview of a specific area where key...
This section called “CME Corner,” highlights, when available, relevant continuing medical education (CME) opportunities deemed to be of use to readers. Articles include an overview of a specific area where key...
This...
03/16/2020
Journal of Clinical Pathways

Feature

Real-World Analysis of Outpatient Rasburicase to Prevent and Manage Tumor Lysis Syndrome in Newly Diagnosed Adults With Leukemia or Lymphoma
Research Reports
Real-World Analysis of Outpatient Rasburicase to Prevent and Manage Tumor Lysis Syndrome in Newly Diagnosed Adults With Leukemia or Lymphoma
03/16/2020
Scott C Howard, MD, MSc
Alex R Cockerham, PharmD, RPh, MSc
Edward Drea, PharmD
Yvonne Barnes, DNP, RN
Michael Ryan
William Irish, PhD
Lucio Gordan, MD
Abstract: Rasburicase, a recombinant urate oxidase used to manage hyperuricemia in patients at risk of tumor lysis syndrome, is increasingly being used in outpatient settings, but outcomes with this approach have not...
Abstract: Rasburicase, a recombinant urate oxidase used to manage hyperuricemia in patients at risk of tumor lysis syndrome, is increasingly being used in outpatient settings, but outcomes with this approach have not...
...
03/16/2020
Journal of Clinical Pathways
The Challenge of Developing Pathways in a Rapidly Evolving Clinical Space: Chronic Lymphocytic Leukemia as a Case Study
Perspectives
The Challenge of Developing Pathways in a Rapidly Evolving Clinical Space: Chronic Lymphocytic Leukemia as a Case Study
03/16/2020
Andrew Hertler, MD, FACP
William A Flood, MD, MS
Ray Page, DO, PhD, FACOI, FASCO
Barry Brooks, MD
Steve L D’Amato, BSPharm, BCOP
Michael Kolodziej, MD
Abstract: Clinical pathways represent an effort to optimize value-based clinical decision making by standardizing (when appropriate) evidence-based care to offer patients the best outcome while remaining mindful of...
Abstract: Clinical pathways represent an effort to optimize value-based clinical decision making by standardizing (when appropriate) evidence-based care to offer patients the best outcome while remaining mindful of...
...
03/16/2020
Journal of Clinical Pathways

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

JCP May/June 2024 Issue

Current Issue

June 2024
Volume 10
Issue 3
Current Issue
Issue Archive

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Special Reports

JCP Special Report
Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group
05/20/2022
Winston Wong, PharmD
Gordon Kuntz
Robin T Zon, MD, FACP, FASCO
2021 Care Pathways Working Group
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways...
05/20/2022
Journal of Clinical Pathways
Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma
Special Report
Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma
01/14/2021
01/14/2021
Journal of Clinical Pathways

Advertisement

Advertisement

Advertisement

Advertisement

Subscribe

Journal of Clinical Pathways Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Volume 6

View Issue Archive
Editorial Correspondence

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement